Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease

被引:8
|
作者
Bruni, Cosimo [1 ,2 ]
Occhipinti, Mariaelena [3 ]
Pienn, Michael [4 ]
Camiciottoli, Gianna [5 ,6 ]
Bartolucci, Maurizio [7 ]
Bosello, Silvia Laura [8 ]
Payer, Christian [9 ]
Balint, Zoltan [10 ]
Larici, Anna Rita [11 ,12 ]
Tottoli, Alessandra [1 ]
Tofani, Lorenzo [1 ,13 ]
De Lorenzis, Enrico [8 ]
Lepri, Gemma [1 ]
Bellando-Randone, Silvia [1 ]
Spinella, Amelia [14 ]
Giuggioli, Dilia [14 ]
Masini, Francesco [15 ]
Cuomo, Giovanna [15 ]
Lavorini, Federico [5 ,6 ]
Colagrande, Stefano [16 ]
Olschewski, Horst [4 ,17 ]
Matucci-Cerinic, Marco [1 ,18 ]
机构
[1] Azienda Osped Univ Careggi, Dept Expt & Clin Med, Div Rheumatol, Via Oblate 4, I-50141 Florence, Italy
[2] Univ Zurich, Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland
[3] Radiomics, Liege, Belgium
[4] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria
[5] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy
[6] Careggi Univ Hosp, Dept CardioThoracoVasc, Florence, Italy
[7] Santo Stefano Hosp, Dept Radiol, Prato, Italy
[8] Fdn Policlin Univ A Gemelli IRCCS, Dept Rheumatol, Rome, Italy
[9] Graz Univ Technol, Inst Comp Graph & Vis, Graz, Austria
[10] Babes Bolyai Univ, Fac Phys, Cluj Napoca, Romania
[11] Univ Cattolica Sacro Cuore, Dept Radiol & Hematol Sci, Sect Radiol, Rome, Italy
[12] Fdn Policlin Univ A Gemelli IRCCS, Dept Diagnost Imaging Oncol Radiotherapy & Hemato, Rome, Italy
[13] Univ Florence, Dept Stat Comp Sci Applicat, Florence, Italy
[14] Univ Modena & Reggio Emilia, Azienda Osped Univ Modena, Dept Med & Surg Sci Children & Adults, Scleroderma Unit,Rheumatol Unit, Modena, Italy
[15] Univ Campania L Vanvitelli, Dept Med Precis, Naples, Italy
[16] Univ Florence, Careggi Univ Hosp, Dept Expt & Clin Biomed Sci, Radiodiagnost Unit 2, Florence, Italy
[17] Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria
[18] IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Dis UnIRAR, Milan, Italy
关键词
systemic sclerosis; interstitial lung disease; lung vessels; PULMONARY ARTERIAL-HYPERTENSION; PATHOGENESIS;
D O I
10.1093/rheumatology/keac311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives It has recently become possible to assess lung vascular and parenchymal changes quantitatively in thoracic CT images using automated software tools. We investigated the vessel parameters of patients with SSc, quantified by CT imaging, and correlated them with interstitial lung disease (ILD) features. Methods SSc patients undergoing standard of care pulmonary function testing and CT evaluation were retrospectively evaluated. CT images were analysed for ILD patterns and total pulmonary vascular volume (PVV) extents with Imbio lung texture analysis. Vascular analysis (volumes, numbers and densities of vessels, separating arteries and veins) was performed with an in-house developed software. A threshold of 5% ILD extent was chosen to define the presence of ILD, and commonly used cut-offs of lung function were adopted. Results A total of 79 patients [52 women, 40 ILD, mean age 56.2 (s.d. 14.2) years, total ILD extent 9.5 (10.7)%, PVV/lung volume % 2.8%] were enrolled. Vascular parameters for total and separated PVV significantly correlated with functional parameters and ILD pattern extents. SSc-associated ILD (SSc-ILD) patients presented with an increased number and volume of arterial vessels, in particular those between 2 and 4 mm of diameter, and with a higher density of arteries and veins of <6 mm in diameter. Considering radiological and functional criteria concomitantly, as well as the descriptive trends from the longitudinal evaluations, the normalized PVVs, vessel numbers and densities increased progressively with the increase/worsening of ILD extent and functional impairment. Conclusion In SSc patients CT vessel parameters increase in parallel with ILD extent and functional impairment, and may represent a biomarker of SSc-ILD severity.
引用
收藏
页码:696 / 706
页数:11
相关论文
共 50 条
  • [1] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [2] Systemic sclerosis-associated interstitial lung disease
    Scallan, Ciaran J.
    Collins, Bridget F.
    Raghu, Ganesh
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 487 - 495
  • [3] Severity and features of frailty in systemic sclerosis-associated interstitial lung disease
    Guler, Sabina A.
    Kwan, Joanne M.
    Winstone, Tiffany A.
    Milne, Kathryn M.
    Dunne, James V.
    Wilcox, Pearce G.
    Ryerson, Christopher J.
    RESPIRATORY MEDICINE, 2017, 129 : 1 - 7
  • [4] Are serum biomarkers useful in the management of systemic sclerosis-associated interstitial lung disease?
    Proudman, Susanna M.
    Corte, Tamera J.
    RESPIROLOGY, 2021, 26 (05) : 406 - 408
  • [5] Management of systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Jaafar, Sara
    Vummidi, Dharshan
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 241 - 249
  • [6] Treatment of systemic sclerosis-associated interstitial lung disease
    Prasse, A.
    Bonella, F.
    Mueller-Ladner, U.
    Witte, T.
    Hunzelmann, N.
    Distler, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 294 - 303
  • [7] Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
    Bonhomme, Olivier
    Andre, Beatrice
    Gester, Fanny
    de Seny, Dominique
    Moermans, Catherine
    Struman, Ingrid
    Louis, Renaud
    Malaise, Michel
    Guiot, Julien
    RHEUMATOLOGY, 2019, 58 (09) : 1534 - 1546
  • [8] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [9] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Koutroumpas, Athanasios
    Ziogas, Athanasios
    Alexiou, Ioannis
    Barouta, Georgia
    Sakkas, Lazaros I.
    CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1167 - 1168
  • [10] Personalized Medicine for Systemic Sclerosis-Associated Interstitial Lung Disease
    Ma, Angela
    Montesi, Sydney B.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2025, 11 (01)